Gold Standard:Tissue-based ARMS-PCR

2 trials

Sponsors

Shanghai Pulmonary Hospital

Conditions

Lung Cancer

Early Phase 1

Utility of BDA-NGS for plasma-based molecular detection and guidance of treatment in patients with advanced NSCLC

Active, not recruitingChiCTR1900026817

Shanghai Pulmonary HospitalLung Cancer

Start: 2019-11-30Updated: 2019-10-28

Utility of BDA-NGS for plasma-based molecular detection and guidance of treatment in patients with advanced NSCLC

Active, not recruitingChiCTR1900027046

Shanghai Pulmonary HospitalLung Cancer

Start: 2019-11-30Updated: 2019-11-04